CME stock

Is CME Group Inc (CME) undervalued? · P/E 22, rev $6.52B

CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.

This page asks whether CME Group Inc (CME) looks cheap on cached numbers — not a DCF toy and not a buy alert.

Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.

CME currently screens at market cap $91.25B and trailing P/E 21.9. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.

A new CME 10-Q can flip this screen overnight. The SEC page is the source.

Not investment advice. Compare CME to the stock page model before you treat a low multiple as a gift.

Not investment advice.

Full CME analysis